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I In nt tr ro od du uc ct ti io on n: : Malignant neoplasm of the colon is one of the most common
gastrointestinal cancers and takes the second place in terms of incidence in the
world. In Asian countries compared with Western countries the incidence is
a bit lower. In recent years in Poland there has been a disturbing increase in
the incidence of this cancer, particularly in the voivodships Mazowieckie, Slaskie,
and Wielkopolskie.
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: : Statistical data from the National Cancer Registry on the
incidence of colorectal cancer in Poland in 1999-2008, including the provinces
which are grouped into provinces of Eastern, Western and Central Poland. We
analysed data on both men and women, with the division of colon cancer, rectal
folds esico and rectum. The analysis took into account the recognized incidence
in absolute numbers and age-standardized incidence rates.
R Re es su ul lt ts s: :   The incidence of colon cancer in 1999 was 3438 cases among men and
3476 women, while in 2008 this number increased in both men and women and
for men was 4763, and 4340 for women. In all Polish provinces, in 1999, 2165
men and 1719 women, and in 2008, 3188 men and 2150 women suffered from
rectal cancer.
C Co on nc cl lu us si io on ns s: : In the years 1999-2008 there was an increase in incidence of cancer
of the colon. In Poland, there are territorial differences in the incidence of
colorectal cancer described by the standardized incidence ratio. The incidence
in Western and Central Poland is generally higher than for Eastern Poland.
Probably, these differences have multiple bases.
K Ke ey y   w wo or rd ds s: : cancer, colon, incidence, statistics, Poland, provinces.
Introduction
Incidence is the incidence of new cases of the disease in the studied
population (according to the Encyclopedia of Small Statistics). One of the
most common cancers in both women and men is cancer of the colon. For
both sexes it is the second most common cause of morbidity [1]. However,
the prevalence of this disease remains higher in men than in women (35%
lower in women) [2].
The most common location of colorectal cancer is the rectum. The
disease is often diagnosed by accident or as a result of screening
(rectoscopy, colonoscopy). Endoscopic assessment is the most effective
method of early detection of neoplastic changes [3]. Delay in diagnosis
and the degree of tumour invasion to adjacent tissues have a decisive
influence on survival [4].
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The  epidemiological  data  suggest  that  the
treatment undertaken in the early stages of the
disease (stage A, B1, B2 Astler-Coller) gives a chance
for 5-year survival in 90%, 85%, and 70% [1] of
cases.  The  aetiology  of  this  disease  is  not
completely known, although research suggests
a number  of  factors  that  could  affect  its
development [5]. The most important are genetic
factors, high-calorie diet rich in fats and low in fibre,
eating  highly  processed  foods  containing
preservatives  and  dyes,  history  of  previous
malignant or benign tumours of the colon (polyps),
breast cancer, ovarian or uterine cancer in women
with ulcerative colitis and Crohn’s disease [6]. Most
cases  are  observed  after  65  years  of  age  [7].
Changes in incidence are differently shaped over
time: in some countries of Northern and Western
Europe the incidence is stabilizing or even gradually
decreasing [8], while in others it is increasing [9].
In the UK, 106 new cases of colorectal cancer are
diagnosed every day [10]. In the United States,
colorectal cancer is the third most common cancer
in both sexes. In 2005, colon cancer and rectal
bending distal segment was diagnosed in 108,100
people and there were 40,800 cases of rectal cancer
[11]. In Germany, in 2006 the total number of cases
was 68,740 [12]. In France, after a steady increase
until  1995,  the  incidence  of  colorectal  cancer
stabilised in both sexes, with a slight decrease in
men. In 2010, the projected incidence was 36.5
per 100,000 in men and 24.4 in women [13].
The aim of this study was to analyse morbidity
among women and men with cancer of the colon
and rectum in Poland in the provinces grouped as
Western, Central and Eastern Poland in 1999-2008.
Material and methods
The basis of this analysis was the incidence of
cancer of the colon and rectum in the years 1999-
2008, included in absolute numbers and described
as the standardized incidence rate according to age.
We analysed incidence rates for the number of
cases per 100 thousand people and standardized
so that the population age structure was the same
as  the  population  age  structure  adopted  as
a standard. The ‘standard world population’ was
adopted as the standard population, and data about
its structure derived from the annual newsletter
‘Cancer Incidence in Five Continents’, edited by
Witold Zatoński and George Tyczyńskiego, issued
by the Department of Epidemiology and Cancer
Prevention – National Cancer Registry. 
The analysis included the incidence by sex and
provinces  called:  Western  Poland  (voivodship:
Zachodniopomorskie, Lubuskie, Dolnośląskie, Greater
Poland), Central Poland (Mazowieckie, Pomorskie,
Kujawsko-pomorskie, Ł￳dzkie, Świętokrzyskie, Lesser
Poland, Silesia, Opole) and Eastern Poland (War  -
mińsko-mazurskie,  Podlaskie,  Lubelskie,  Pod  -
karpackie). By grouping the provinces the average
incidence rate was calculated for the group of
provinces based on the ratios for each province
(arithmetic average). Statistical data were drawn
from the National Institute of Hygiene in Warsaw.
Results
Tables I and II include the absolute incidence of
colorectal cancer in the years 1999-2008, by gender
and location of the cancer of the colon and rectum
for cancer separately. Tables III to IV present the
incidence of colorectal cancer by gender expressed
as the standardized incidence rate of Poland's
Western, Central and Eastern provinces in the years
1999-2008.
On the basis of data on incidence of cancer of
the colon in the years 1999-2008 there can be
observed a rise in incidence of cancer of the colon
and rectum, both for women and men. In 1999, the
incidence of colon cancer was 3438 for men and
3476 for women, and in 2008 respectively 4763 and
4340 (Table I, Figure 1). In 1999, 2165 men and 1719
women suffered from rectal cancer. In subsequent
years, the incidence increased, reaching respectively
3188 and 2150 in 2008 (Table II, Figure 2).
G Ge en nd de er r Y Ye ea ar r
1 19 99 99 9 2 20 00 00 0 2 20 00 01 1 2 20 00 02 2 2 20 00 03 3 2 20 00 04 4 2 20 00 05 5 2 20 00 06 6 2 20 00 07 7 2 20 00 08 8
Men 3438 3345 3689 3675 4184 4205 4442 4486 4743 4763
Women 3476 3389 3583 3575 3882 3961 4123 4057 4254 4340
T Ta ab bl le e   I I. .   Prevalence (in absolute terms) for colon cancer in men and women in Poland in 1999-2008
G Ge en nd de er r Y Ye ea ar r
1 19 99 99 9 2 20 00 00 0 2 20 00 01 1 2 20 00 02 2 2 20 00 03 3 2 20 00 04 4 2 20 00 05 5 2 20 00 06 6 2 20 00 07 7 2 20 00 08 8
Men 2165 2474 2597 2685 2790 2716 3043 3075 3149 3188
Women 1719 1921 1881 2032 2061 1995 2092 2006 2098 2150
T Ta ab bl le e   I II I. .   Incidence (in absolute terms) of rectal cancer for men and women in Poland in 1999-2008Arch Med Sci 4, August / 2011 675
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R Re eg gi io on n Y Ye ea ar r
1 19 99 99 9 2 20 00 00 0 2 20 00 01 1 2 20 00 02 2 2 20 00 03 3 2 20 00 04 4 2 20 00 05 5 2 20 00 06 6 2 20 00 07 7 2 20 00 08 8
West Poland  14.0 15.1 16.6 14.7 18.3 18.8 19.4 19.1 19.5 19.2
Central Poland 15.6 14.4 15.0 15.0 16.4 16.1 15.9 16.3 17.7 17.6
East Poland 11.8 11.4 13.5 14.5 14.9 16.5 20.5 15.3 16.3 16.0
Poland 14.6 14.0 15.2 14.9 16.8 16.5 17.0 17.0 17.6 17.4
T Ta ab bl le e   I II II IA A. .Incidence of colon cancer in 1999-2008 (standardized coefficient) in Western, Central, Eastern Poland – men
R Re eg gi io on n Y Ye ea ar r
1 19 99 99 9 2 20 00 00 0 2 20 00 01 1 2 20 00 02 2 2 20 00 03 3 2 20 00 04 4 2 20 00 05 5 2 20 00 06 6 2 20 00 07 7 2 20 00 08 8
West Poland  9.3 10.5 10.4 10.8 11.7 11.2 12.1 11.5 12.6 12.2
Central Poland 10.9 9.8 10.9 9.9 10.4 10.6 10.7 10.9 11.0 11.1
East Poland 8.7 8.0 8.6 9.0 10.0 9.7 11.3 10.5 10.1 10.8
Poland 10.3 9.9 10.4 10.1 10.9 10.7 11.1 10.9 11.1 11.1
T Ta ab bl le e   I II II IB B. .Incidence of colon cancer in 1999-2008 (standardized coefficient) in Western, Central, Eastern Poland – women
R Re eg gi io on n Y Ye ea ar r
1 19 99 99 9 2 20 00 00 0 2 20 00 01 1 2 20 00 02 2 2 20 00 03 3 2 20 00 04 4 2 20 00 05 5 2 20 00 06 6 2 20 00 07 7 2 20 00 08 8
West Poland  10.1 11.3 11.4 12.4 11.8 11.4 13.5 12.6 13.1 12.6
Central Poland 9.0 10.5 10.6 11.1 11.0 11.0 11.5 11.4 11.5 11.7
East Poland 7.9 10.8 11.8 9.9 11.5 11.6 11.9 12.1 11.9 12.6
Poland 9.3 10.5 10.8 11.0 11.3 10.8 11.7 11.8 11.8 11.8
T Ta ab bl le e   I IV VA A. .   Incidence of rectal cancer (C20) in 1999-2008 (standardized coefficient) in Western, Central, Eastern Poland – men
R Re eg gi io on n Y Ye ea ar r
1 19 99 99 9 2 20 00 00 0 2 20 00 01 1 2 20 00 02 2 2 20 00 03 3 2 20 00 04 4 2 20 00 05 5 2 20 00 06 6 2 20 00 07 7 2 20 00 08 8
West Poland  5.4 5.7 5.5 6.6 6.6 6.4 6.0 5.8 6.2 6.9
Central Poland 5.2 5.7 5.1 5.6 5.9 5.7 5.5 5.4 5.5 5.3
East Poland 4.0 6.0 6.0 6.3 5.8 5.3 6.5 5.6 5.4 5.8
Poland 5.2 5.7 5.4 5.8 5.9 5.6 5.8 5.4 5.6 5.6
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F Fi ig gu ur re e   2 2. .   Incidence of rectal cancer in men and
women in Poland in 1999-2008
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As is apparent from Tables IIIA and IIIB, in 1999
the highest standardized incidence rate for colon
cancer is observed for Central Poland at 15.6 for
men and 10.9 for women (above the Polish value
of 14.6 for men and 10.3 for women), the lowest for
Eastern Poland at 11.8 for men and 8.7 for women
(below the Polish value). In Western Poland it
reached the average level of 14.0 for men and 9.3
for women. In the years 1999-2008 there was an
increase in the incidence rate among men, in 2008
amounting to 17.4 for Poland, 19.2 for Western, 17.6
for Central and 16.0 for Eastern Poland. The highest
growth  rate  occurred  for  the  Polish  western
provinces – a 5.2. For women in 1999-2008 the
incidence rate increased and in 2008 reached the
level of 11.1, and 12.2 for Western, 10.8 for Eastern,
and 11.1 for Central Poland. Change rate trends in
1999-2008 are illustrated in Figures IIIA and IIIB.
As is apparent from Table IVA and IVB, in 1999,
the standardized incidence rate of rectal cancer
(C20) was lower than that of colon cancer and
showed little territorial difference, reaching in males
the average level of 9.3 for the provinces of Western
(10.1), Central (9.0) and Eastern Poland (7.9). For
women, it reached respectively 5.4, 5.2, 5.1 and 4.0.
In the years 1999-2008 there was an increase in
incidence rate in both men and women, in 2008
reaching  respectively  for  Polish  males  11.8,  in
Western 12.6, Central 11.7, and Eastern Poland 12.6.
For women the values were respectively 6.9, 5.3,
and 5.8. Change rate trends in 1999-2008 are
illustrated in Figures IVA and IVB.
Discussion
Malignant tumours of the colon are a major
cause of morbidity and mortality worldwide. They
are more prevalent in developed countries than in
developing countries, which may indicate a link with
the horizontal life. In the UK every day 106 new
cases of colon cancer are diagnosed [10]. In the
United States, colorectal cancer is the third most
common cancer in both sexes. In 2005, 108,100
people were diagnosed with colon cancer and rectal
bending distal segment and 40,800 with rectal
cancer [11]. In Germany, in 2006 the total number
of cases stood at 68,740 [12]. There are differently








F Fi ig gu ur re e   4 4. . Incidence of rectal cancer (C20) in 1999-2008 (standardized coefficient) for Western, Central, Eastern Poland.


























F Fi ig gu ur re e   3 3. . Incidence of colon cancer in 1999-2008 (standardized coefficient) for Western, Central, Eastern Poland. 
A A – men, B B – women
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shaped incidence changes over time: in some
countries of Northern and Western Europe the
incidence  is  stabilizing  and  even  gradually
decreasing [8], while in others it is increasing [9]. 
As is clear from the statistical data, colorectal
cancer affects both sexes, but it is significantly more
frequent in men, regardless of location of the
tumour. In Poland, the epidemiological situation
regarding this disease is alarming. Since 1999 we
can observe an increase in incidence in both sexes
expressed  in  absolute  numbers.  The  rise  in
incidence rates is also illustrated by Polish and
province  groups  standardized  rates  (with  the
exception of the above-mentioned colon cancer in
women). In both locations, higher colorectal cancer
incidence rates occur in men than in women, which
indicates the relationship of this type of cancer with
sex. Hormone substrate is considered one of the
reasons for these differences.
In women, the first pregnancy at a young age,
oral  contraception  and  oestrogen  replacement
therapy  are  associated  with  reduced  risk  of
developing  colorectal  cancer  [14,  15].  In  the
Women's  Health  Initiative  study,  hormone
replacement therapy showed 40% reduction in the
risk of colorectal cancer [16]. In total, these data
suggest that oestrogen and/or progestins protect
against  colon  cancer.  Territorial  differences
expressed in averaged standardized incidence rate
for groups of provinces of Western, Central and
Eastern Poland appear to be interesting. Thus, for
colon cancer (C18) in 1999, the highest incidence
rate (above the Polish figure) occurred in males in
the Polish Central provinces.
However, by 2008 the growth rate was higher in
Western and Eastern than in Central Poland. For
women at the same time there was a slight drop
in the rate in Central Poland and growth in Western
(above the figure for Poland) and Eastern Poland
(slightly below the Polish figure). In the case of
rectal cancer (C20) in 1999, the highest incidence
rate occurred in Western Poland, for both men and
women (above the Polish value), as was also the
case in 2008.
For the years 1999-2008 between the Western,
Central and Eastern Polish provinces there are
territorial differences in the incidence of colorectal
cancer  (expressed  as  the  mean  standardized
incidence ratio), but higher incidence generally
refers to the Western and Central Polish provinces
rather than Eastern Poland.
The explanation for the observed differences
requires further territorial epidemiological studies.
They may depend on factors affecting the increased
incidence of cancer (e.g., diet, socioeconomic status,
genetic factors) as well as on factors affecting the
rate of detectability (e.g., access to screening,
patients' awareness, experience, doctors).
Summarizing the above results, we can conclude
that for the two locations of colon cancer, increased
incidence is observed for cancers of the colon, and
it  occurs  more  often  in  men  than  in  women.
Perhaps this is due to a diet rich in fats, particularly
animal fats, which not only causes obesity, but also
increases the risk for colon cancer. Drinking too
much alcohol and smoking also may play a role in
the development of colorectal cancer [17]. Smokers
are 20-30% more likely to die of colon cancer than
non-smokers [18]. Differences in the incidence of
colorectal cancer among men and women may
result from differential expression of oestrogen
receptors, which may play a significant role in the
pathogenesis of this tumour.
Oestrogens are used to reduce menopausal
symptoms and for preservation of bone mineral
density. Recent epidemiological studies suggest that
combined oestrogen and progestin in hormone
replacement  therapy  reduces  the  incidence  of
colorectal cancer in postmenopausal women [19,
20]. Other epidemiological studies suggest that
oestrogen withdrawal increases the risk of MSI-
positive colorectal cancer [21]. Therefore, hormone
replacement therapy plays such a prominent role
and oestrogens seem to have a protective effect
against this type of cancer.
In conclusion, the increase in the incidence of
colorectal cancer may be the result of the increased
availability  of  endoscopic  examinations.  The
differences in incidence between western and
eastern  Poland  may  result  from  the  better
economic situation of inhabitants of the west, and
hence of a diet rich in conserved foods. Lack of
territorial differences in the number of cases in
Poland may be the result of the general access to
rectoscopic examination throughout the country.
The differences in the incidence of colorectal cancer
among men and women may be associated with
the hormonal substrate.
Testing for colon cancer may be relevant to the
analysis of the causes of territorial differences in
the incidence of mortality. Differences in mortality
may, inter alia, indicate the dominant role of either
dietary factors or the availability of medical care.
Irrespective of the epidemiological studies, the
results of many years of genetic research can play
an important role in the analysis of the causes of
morbidity of colorectal cancer.
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